Newsom vetoed a bill that would have required insurers to cover, and pharmacists to dispense, 12 months of hormone therapy at one time to transgender patients and others.

Acadia Pharmaceuticals CEO Catherine Owen Adams breaks down the company’s recent rebrand, its expansion into rare disease marketing and how it’s using AI.

President Trump wants to lower GLP-1 prices; Novo Nordisk hires new corporate affairs lead; FDA announces priority drug review candidates.

The Food and Drug Administration (FDA) has sent out 12 more Untitled Letters to pharma companies amid its ongoing crackdown ...

Real Chemistry bought Spring & Bond, a New York-based digital media agency, on Wednesday morning. Financial terms were not ...

Industry analysts have suggested both Publicis Groupe and Havas could be potential acquirers of Dentsu’s international ...

NMDP, a global non-profit partnered with AI influencer Lil Miquela to share her leukemia journey with her 2.3 million instagram followers.

Eli Lilly’s weight loss pill showed better blood sugar control in late trials. Orforglipron is designed to mimic the GLP-1 hormone, and features tirzepatide as an active ingredient. (Reuters) Novo ...

Lina Polimeni was promoted to SVP and chief marketing office, consumer at Eli Lilly. Citrus Health Group, a 2025 MM+M Agency ...

The company’s recent creator effectiveness report underscored the need for dependable measurement in the category.

Susan Perlbachs, chief creative officer of Eversana Intouch, discusses how marketers are navigating a new world order of scrutiny.

Sora, OpenAI’s new social media app, has the power to transform medical marketing — here’s a peek into what it can do.